J 2026

Resilient innovation and entrepreneurial responses to systemic shocks: Economic insights into sustainable business ecosystems

POLLÁK, František; Kristián KALAMEN; Roman VAVREK and Jaroslava GBUROVÁ

Basic information

Original name

Resilient innovation and entrepreneurial responses to systemic shocks: Economic insights into sustainable business ecosystems

Authors

POLLÁK, František; Kristián KALAMEN; Roman VAVREK and Jaroslava GBUROVÁ

Edition

Sustainable Technology and Entrepreneurship, 2026, 2773-0328

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

50200 5.2 Economics and Business

Country of publisher

Spain

Confidentiality degree

is not subject to a state or trade secret

References:

Marked to be transferred to RIV

Yes

RIV identification code

RIV/75081431:_____/26:00002944

Organization unit

Institute of Technology and Business in České Budějovice

EID Scopus

Keywords in English

Sustainable finance; Sustainable business ecosystems; Economic development; Entrepreneurship; Investor behavior; COVID-19 pandemic

Tags

Changed: 2/1/2026 13:52, Ing. Barbora Langšádlová

Abstract

In the original language

The COVID-19 pandemic exposed systemic vulnerabilities in financial markets and raised pressing questions regarding the resilience of technology and entrepreneurship under shock. This study investigates whether two innovation-intensive sectors, technology and pharmaceuticals, exhibited synchronization with the S&P 500 across eleven epidemiologically defined phases (March 2019–December 2022). Using a robust methodological framework, a crisis-aware synchronization model was developed to detect real-time versus delayed investor alignment. A key novelty of the approach is the incorporation of time lags as a relevant factor influencing responses to systemic shocks. Results show that the technology sector exhibited statistically significant contemporaneous co-movement, consistent with its role as continuity-enabling digital infrastructure, whereas pharmaceutical sector demonstrated episodic, event-driven co-movement concentrated around vaccine and policy milestones. Notably, correlations during pandemic waves were not stronger than during inter-wave periods for either sector. These findings extend the Adaptive Markets Hypothesis by introducing a sector-contingent perspective: structural integrators (technology) stabilize expectations in real time, while event-contingent innovators (pharmaceuticals) generate punctuated alignment. For sustainable finance and entrepreneurship, the results suggest actionable levers: technology should be treated as a portfolio anchor and a policy priority for resilient digital infrastructure (measured in terms of uptime, scalability, energy efficiency), while pharmaceuticals should be considered a tactical complement, with innovation surges converted into durable capacity.

Files attached

separat_-_Pollak__IDUPS25051_.pdf
Request the author's version of the file